4 minute read
Appointments
The IRCM Foundation announces the appointment of Brian Gelfand to its board of directors. Gelfand is vicepresident of institutional relations and market operations at the Montréal Exchange and has previously worked as a consultant, an attorney, and a special advisor to the Secretary General at the International Organization of Securities Commissions. He is a member of the Bars of Quebec, New York and Massachusetts.
Canada’s National Institute for Nanotechnology (NINT) has named Dr. Marie D’Iorio as its new executive director. Trained as a physicist, Dr. D’Iorio’s expertise
Advertisement
is in nano-electronics. She has been acting as NINT’s interim director general since last year. Dr. D’Iorio joined NRC in 1983, where she established the fi rst very low temperature, high magnetic fi eld laboratory in Canada to study low dimensional electron systems in semiconductor heterostructures. She served as director general of the National Research Council of Canada Institute for Microstructural Sciences from 2003 to 2011. She obtained a PhD in solid-state physics in 1982 from the University of Toronto, and then spent a year as a post-doctoral fellow at the IBM Zurich Research Laboratory in Switzerland.
Molecular biologist Dr. John Capone has been named as new vice-president (research) of the University of Western Ontario. Currently serving his second term as McMaster University’s dean of science, Dr. Capone is recognized as one of Canada’s foremost molecular biologists. He begins his fi ve-year term on October 1. In his new position at Western, Dr Capone says he plans to build research capacity through faculty renewal, multi-disciplinary partnerships, embedding research at the undergraduate level and connecting research activity to educational excellence. He obtained a BSc in biochemistry from Western in 1978 and a PhD in biochemistry from McMaster University in 1983. From 1983 to 1986, he was a Medical Research Council of Canada centennial post-doctoral fellow at the Massachusetts Institute of Technology (MIT). He returned to McMaster as an assistant professor in the department of biochemistry in 1986 and was promoted to professor in 1995. He became chair of the department of biochemistry in 1997 and was appointed McMaster’s faculty of health sciences’ associate dean of research in 2000. Following a fi ve-year term, he was appointed dean of McMaster’s Faculty of Science on July 1, 2005.
Winnipeg-based biopharmaceutical company Cangene Corporation announces it has appointed Jeff Lamothe as its new chief fi nancial offi cer commencing Aug. 1, 2012. Lamothe brings over 20 years business and fi nancial experience to Cangene. He will be working out of Cangene’s Winnipeg headquarters, where he will oversee the hospital-based therapeutics company. Currently, Lamothe is CFO for Smith Carter Architects and Engineers Incorporated. Before that, he was president and CEO of Kitchen Craft Cabinetry, after occupying the position of VP Finance and CFO at that company. His past experiences include being CFO of Motor Coach Initiatives and working at James Richardson & Sons, Limited and Ernst & Young LLP.
The Ontario Hospital Association (OHA) welcomes Pat Campbell as its new President and CEO. Campbell is an accomplished health care leader with a wide range of experience in rural, community and academic hospital environments. She joins the OHA from Echo: Improving Women’s Health In Ontario, an agency of the Ministry of Health and Long-Term Care. Before that, Pat served as president and CEO of Grey Bruce Health Services and Women’s College Hospital in Toronto.
BIOTECanada announces the appointment of Andrew Casey as the association’s new president and CEO starting July 30, 2012. Casey joins the biotech industry after spending almost 20 years in senior roles in the national trade association business. Currently, Casey is the vice president of public affairs and international trade with the Forest Products Association of Canada (FPAC). Prior to joining the FPAC, Casey was assistant vice president, government relations, for the Canadian Life and Health Insurance Association. The announcement was made by Brad Thompson, the chairman of BIOTECanada, who welcomed Casey to the industry and to the association.
Sue Paish has been named the new CEO for LifeLabs. She joins LifeLabs from Pharmasave Drugs. Prior to joining Pharmasave, Paish was the managing partner of Fasken Martineau DuMoulin in B.C. She sits on a number of corporate and community boards including the Michael Smith Foundation for Health Research, the Rick Hansen Foundation and the CORIX Group of Companies. She begins in her new role as CEO of LifeLabs on July 1.
David Gauthier succeeds Wilf Keller as president of Genome Prairie. Gauthier is a private consultant specializing in investment and technology commercialization. He has served as director of business development with Performance Plants Inc., vice-president of Foragen Technologies Management Inc., regional director of the National Research Council’s Canada Industrial Research Assistance Program and most recently CEO of the Entrepreneurial Foundation of Saskatchewan. Stepping down as Genome Prairie’s president allows Keller to make his current role with Ag-West Bio a full-time position. Keller had held the dual roles since April 2010, when a management agreement was struck between the two organizations
